BVS
Bioventus Inc.
Next earnings Aug 4, 2026 · consensus $0.22 EPS, $157M rev
Last earnings +2.2% on 2026-05-06
$9.73▲ +48.55%
over 1Y
L $6.14EODHDH $10.94
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today—
1W+11.7%
1M+7.9%
3M+5.1%
YTD+35.0%
1Y+48.5%
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 9 analysts
Buy
Revenue declined -0.9% YoY.
Bioventus Inc. shows $568M in FY2025 revenue (-0.9% YoY), a 4.0% net margin, and 12.3% ROE.
Sources: SEC EDGAR (CIK 0001665988, latest 10-Q filed 2026-05-06) · as of 6/26/2026, 7:22:24 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.